CDW Corp: Form 10-K for the period ended Dec 31, 2014
Filed with the SEC on Feb 26, 2015 and accepted by EDGAR at Feb 26, 2015, 12:01 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-01 to 2014-12-31 | $3.05bn | us-gaap:SalesRevenueNet |
| Revenue | 12 months2014-01-01 to 2014-12-31 | $12.07bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2014-01-01 to 2014-12-31 | $10.15bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2014-10-01 to 2014-12-31 | $491.9m | us-gaap:GrossProfit |
| Gross profit | 12 months2014-01-01 to 2014-12-31 | $1.92bn | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2014-01-01 to 2014-12-31 | $1.11bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-10-01 to 2014-12-31 | $164.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2014-01-01 to 2014-12-31 | $673.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2014-01-01 to 2014-12-31 | $142.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-01 to 2014-12-31 | $51.8m | us-gaap:NetIncomeLoss |
| Net income | 12 months2014-01-01 to 2014-12-31 | $244.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-01 to 2014-12-31 | $0.30 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2014-01-01 to 2014-12-31 | $1.42 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-01 to 2014-12-31 | $0.30 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2014-01-01 to 2014-12-31 | $1.44 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2014-01-01 to 2014-12-31 | 172,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2014-01-01 to 2014-12-31 | $435.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 12 months2014-01-01 to 2014-12-31 | $33.6m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2014-01-01 to 2014-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-12-31 | $344.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-31 | $2.45bn | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-31 | $6.10bn | us-gaap:Assets |
| Current liabilities | At period end2014-12-31 | $1.47bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2014-12-31 | $3.17bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2014-12-31 | $15.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2014-12-31 | $936.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001402057-15-000003. Last ingested by Listed: Nov 4, 2026, 16:25 ET. Listed shows no prices and gives no investment advice.